Advanced Prostate Cancer Drug May Help at Earlier Stage published on May 17th, 2012 at 10:51 PM WEDNESDAY, May 16 (HealthDay News) -- A drug approved to treat advanced prostate cancer appears to help men who have localized high-risk prostate cancer if given before surgery.
New York judge with cancer makes case for marijuana published on May 17th, 2012 at 10:51 PM NEW YORK (Reuters) - A cancer-stricken judge in New York has become an unlikely voice in support of legalizing the use of medical marijuana with the admission that he smokes pot to ease the side-effects of his treatments. Brooklyn Supreme Court Justice Gustin Reichbach, who is being treated for pancreatic cancer, wrote in a New York Times article on Thursday that he had been using marijuana provided by friends at "great personal risk" to help him cope with the nausea, sleeplessness and loss of appetite from chemotherapy treatments. ...
Texas Researchers Report Promising Breast Cancer Vaccine published on May 17th, 2012 at 10:51 PM Researchers at the University of Texas M.D. Anderson Hospital have reported good results on what amounts to a vaccine that helps to prevent the re-occurrence of breast cancer.
LONDON (Reuters) - Scientists have mapped the complete genetic codes of 21 breast cancers and created a catalogue of the mutations that accumulate in breast cells, raising hopes that the disease may be able to be spotted earlier and treated more effectively in future. The research, the first of its kind, untangles the genetic history of how cancer evolves, allowing scientists to identify mutational patterns that fuel the growth of breast tumors, and start to work out the processes behind them. ...
(Reuters) - Adding Johnson & Johnson's advanced prostate cancer drug, Zytiga, to hormone therapy before surgery has been shown for the first time to eradicate tumors in some men with high-risk forms of the disease. The mid-stage trial found that six months of treatment with the combination therapy completely or nearly eliminated the cancer in a third of patients, all of whom had localized, aggressive cancer. ...
India's World Cup hero Yuvraj Singh hopes to return to cricket in "three to four months" after recovering from a cancerous tumour, media reports said on Thursday.
Array shares rise on lung cancer, melanoma results published on May 16th, 2012 at 10:51 PM (Reuters) - Array BioPharma Inc's experimental lung cancer drug, selumetinib, w as shown to increase survival by an additional 4.2 months over chemotherapy alone, according to new data released on Wednesday. The company also reported encouraging results of a new melanoma treatment, and its shares rose 5 percent after-hours. Array, which has licensed the lung cancer drug to AstraZeneca Plc, announced last year that a mid-stage trial had failed to meet its main goal of showing statistically significant improvement in overall survival. ...
(Reuters) - Adding Johnson & Johnson's advanced prostate cancer drug, Zytiga, to hormone therapy before surgery has been shown for the first time to eradicate tumors in some men with high-risk forms of the disease. The mid-stage trial found that six months of treatment with the combination therapy completely or nearly eliminated the cancer in a third of patients, all of whom had localized, aggressive cancer. ...
Aveo kidney cancer drug more tolerated than Nexavar published on May 16th, 2012 at 10:51 PM (Reuters) - Patients taking a kidney cancer drug being developed by Aveo Pharmaceuticals Inc were half as likely to need a break from the medication due to side effects than those on the widely used medicine Nexavar, according to data released on Wednesday. There were also significantly fewer patients taking Aveo's tivozanib who required a dose reduction than those on Nexavar. ...
Britain to fund prostate cancer pill in U-turn published on May 15th, 2012 at 10:51 PM LONDON (Reuters) - Britain's drug watchdog has reversed a controversial decision not to fund a new prostate cancer pill that was developed in the country after maker Johnson & Johnson agreed a new discount on supplies to the UK state healthcare service. Zytiga, which is known chemically as abiraterone, was approved last year in Europe and the United States to treat advanced prostate cancer in patients who previously received chemotherapy. The drug was developed by researchers at the Institute of Cancer Research and London's Royal Marsden Hospital. ...
Britain to fund prostate cancer pill in U-turn published on May 15th, 2012 at 10:51 PM LONDON (Reuters) - Britain's drug watchdog has reversed a controversial decision not to fund a new prostate cancer pill that was developed in the country after maker Johnson & Johnson agreed a new discount on supplies to the UK state healthcare service. Zytiga, which is known chemically as abiraterone, was approved last year in Europe and the United States to treat advanced prostate cancer in patients who previously received chemotherapy. The drug was developed by researchers at the Institute of Cancer Research and London's Royal Marsden Hospital. ...
Common Blood Pressure Drugs May Not Cut Colon Cancer Risk published on May 14th, 2012 at 10:51 PM MONDAY, May 14 (HealthDay News) -- Widely used blood pressure medications called beta blockers do not cut a person's odds of developing colon cancer, a new study contends.
Colon cancer test may not require laxatives: study published on May 14th, 2012 at 10:51 PM NEW YORK (Reuters Health) - People getting checked for signs of colon cancer may not need to take a laxative if they choose a CT scan for their cancer screening over a tradition colonoscopy, according to a new study. The findings suggest a so-called CT colonography is almost as good at identifying certain polyps as a traditional colonoscopy, and researchers said eliminating the need for laxatives may encourage more people to get screened. "The results of this study open the door to a more patient-friendly screening," said Dr. ...
Ill.: Scratch-off raises $8.5M for breast cancer published on May 14th, 2012 at 10:51 PM Illinois officials say a scratch-off lottery ticket launched in 2006 has raised more than $8.5 million for breast cancer research and education.
Ousted Yahoo! chief executive Scott Thompson told board members before his resignation that he has cancer, the Wall Street Journal reported Monday.
Yahoo's Thompson reportedly has thyroid cancer published on May 14th, 2012 at 10:51 PM Yahoo's Scott Thompson, who was pressured to give up his CEO post because his official biography included a college degree he never received, reportedly has thyroid cancer.
The Wall Street Journal reports that shortly before stepping down as CEO, Scott Thompson told Yahoo's board that he was recently diagnosed with thyroid cancer. The health issue adds another surprising wrinkle to the controversy around Thompson and his resumé fudging. While the health issue allowed him to cite "personal reasons" as the impetus for his departure, Kara Swisher reported early this morning that Yahoo is officially designating his departure as "for cause. ...
CARACAS (Reuters) - Venezuelan President Hugo Chavez strode, sang and gave a rousing speech on Friday in a careful show of vigor after his latest cancer treatment in Cuba fanned rumors he was dying five months before an election. The socialist Chavez, who had only been seen live in public once in the previous month, addressed the nation after flying back from Havana where he has completed six rounds of radiation therapy. ...
Venezuelan President Hugo Chavez returned home from Havana late Friday, declaring success in his fight against cancer after a week in which he received what was supposed to be his last session of radiation therapy.
A video featuring cancer-stricken children, their nurses, doctors and parents lip-synching and dancing to the popular Kelly Clarkson song "Stronger" has become an online sensation.
Birth defects linked to childhood cancer: study published on May 11th, 2012 at 10:51 PM NEW YORK (Reuters Health) - A new study suggests children born with a range of birth defects are at an increased risk of developing certain childhood cancers, especially during their first year of life. The cancers, however, are generally rare and the study cannot say one condition causes the other -- just that there is a link. The finding "does sort of point to a global relationship to whatever is driving birth defects and what is driving childhood cancers," said Susan Carozza, a cancer researcher at Oregon State University in Corvallis. ...
Many Young Adults at Risk of Skin Cancer: CDC published on May 10th, 2012 at 10:51 PM THURSDAY, May 10 (HealthDay News) -- Despite warnings about the dangers of excess sun exposure, young adults in the United States still get sunburned or use indoor tanning beds, federal health officials said Thursday.
